Skip to main navigation Skip to search Skip to main content

Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP/PS1 mice, a model of Alzheimer's disease

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
JournalNeuropharmacology
VolumeTBC
DOIs
Publication statusPublished (in print/issue) - 2013

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this